95 related articles for article (PubMed ID: 1482561)
1. Omeprazole-like compounds on histamine-stimulated acid and peptic secretions in conscious dog and cat.
Chiavarini M; Barocelli E; Ballabeni V; Razzetti R; Impicciatore M
Boll Soc Ital Biol Sper; 1992 Jul; 68(7):429-36. PubMed ID: 1482561
[TBL] [Abstract][Full Text] [Related]
2. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
[TBL] [Abstract][Full Text] [Related]
3. Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
Satoh H; Inatomi N; Nagaya H; Inada I; Nohara A; Nakamura N; Maki Y
J Pharmacol Exp Ther; 1989 Feb; 248(2):806-15. PubMed ID: 2537418
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of gastric acid secretion by omeprazole in the dog and rat.
Larsson H; Carlsson E; Junggren U; Olbe L; Sjöstrand SE; Skånberg I; Sundell G
Gastroenterology; 1983 Oct; 85(4):900-7. PubMed ID: 6884713
[TBL] [Abstract][Full Text] [Related]
5. Effects of omeprazole, a substituted benzimidazole, on gastrointestinal secretions, serum gastrin, and gastric mucosal blood flow in dogs.
Konturek SJ; Cieszkowski M; Kwiecień N; Konturek J; Tasler J; Bilski J
Gastroenterology; 1984 Jan; 86(1):71-7. PubMed ID: 6689674
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
Wallmark B; Lorentzon P; Larsson H
Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
[TBL] [Abstract][Full Text] [Related]
7. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological regulation of gastric acid secretion in the apical membrane of parietal cells; a new target for antisecretory drugs.
Okabe S; Shimosako K; Amagase K
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):639-56. PubMed ID: 11787764
[TBL] [Abstract][Full Text] [Related]
9. Dissociated response of acid and pepsin secretion to omeprazole in an in vitro perfused mouse stomach.
Fimmel CJ; Berger MM; Blum AL
Am J Physiol; 1984 Sep; 247(3 Pt 1):G240-7. PubMed ID: 6089588
[TBL] [Abstract][Full Text] [Related]
10. Parietal cell structure during inhibition of acid secretion.
Helander HF
Scand J Gastroenterol Suppl; 1984; 101():21-6. PubMed ID: 6599538
[TBL] [Abstract][Full Text] [Related]
11. Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione.
Fujisaki H; Shibata H; Oketani K; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Yamaguchi M; Sakai H; Takeguchi N
Biochem Pharmacol; 1991 Jul; 42(2):321-8. PubMed ID: 1650210
[TBL] [Abstract][Full Text] [Related]
12. Pepsin secretion: neurohumoral regulation and drug effects.
Fimmel CJ; Blum AL
Scand J Gastroenterol Suppl; 1984; 101():39-46. PubMed ID: 6100625
[TBL] [Abstract][Full Text] [Related]
13. Effects of misoprostol on histamine-related gastric secretion in man.
Wilson DE; Wilson PC
J Assoc Acad Minor Phys; 1989; 1(1):16-8. PubMed ID: 2520847
[TBL] [Abstract][Full Text] [Related]
14. Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans.
Olbe L; Haglund U; Leth R; Lind T; Cederberg C; Ekenved G; Elander B; Fellenius E; Lundborg P; Wallmark B
Gastroenterology; 1982 Jul; 83(1 Pt 2):193-8. PubMed ID: 6282679
[No Abstract] [Full Text] [Related]
15. The effect of secretagogue selection on potency determinations for gastric acid antisecretory agents.
Palumbo GJ; Nielsen ST
Methods Find Exp Clin Pharmacol; 1988 Mar; 10(3):151-5. PubMed ID: 2898575
[TBL] [Abstract][Full Text] [Related]
16. Effect of vasoactive intestinal peptide on gastric secretion in the cat.
Vagne M; Konturek SJ; Chayvialle JA
Gastroenterology; 1982 Jul; 83(1 Pt 2):250-5. PubMed ID: 6806139
[TBL] [Abstract][Full Text] [Related]
17. Validation of a conscious rat model for the discovery of novel agents that inhibit gastric acid secretion.
Campbell CA; Gaskin PJ; Darton J; Chiu P; Lee K; McLean PG
Eur J Pharmacol; 2008 Jul; 589(1-3):260-3. PubMed ID: 18571645
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effect of omeprazole--a substituted benzimidazole--and ranitidine--a potent H2-receptor antagonist--on histamine-induced gastric acid secretion and the ultrastructure of canine parietal cells.
Stachura J; Konturek SJ; Cieszkowsky M; Dabroś W; Zakrzewska J; Konturek J
Hepatogastroenterology; 1983 Oct; 30(5):205-10. PubMed ID: 6315556
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of acid and pepsin secretions in fistulated cats by dimaprit-like compounds.
Impicciatore M; Chiavarini M; Razzetti R; Plazzi P
Farmaco Sci; 1980 May; 35(5):418-24. PubMed ID: 6450062
[TBL] [Abstract][Full Text] [Related]
20. Chronic administration of H2-antagonists does not alter gastric secretory responses to histamine, or the antisecretory activity of sufotidine.
Stables R; Humphray JM; Reeves JJ
Aliment Pharmacol Ther; 1990; 4 Suppl 1():7-13. PubMed ID: 1983348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
